ClinConnect ClinConnect Logo
Search / Trial NCT04333797

Psychiatry of Transition in a World in Transition

Launched by QUEEN FABIOLA CHILDREN'S UNIVERSITY HOSPITAL · Apr 2, 2020

Trial Information

Current as of November 11, 2025

Recruiting

Keywords

Transitional Age Youth Camhs Amhs Dimensional Approach Child And Adolescent Psychiatry Services Adult Psychiatry Services

ClinConnect Summary

This clinical trial, called "Psychiatry of Transition in a World in Transition," is studying how certain factors can affect the mental health of young people aged 17. The researchers want to understand both the risks and protective factors that could lead to mental health challenges during this important stage of life. To do this, they will recruit 300 participants and follow up with them two years later to see how they are doing.

To participate, individuals need to be able to speak and understand French and give their consent to be part of the study, which also requires permission from a parent or guardian. Eligible participants include young people who are currently receiving treatment in hospitals or outpatient clinics, as well as those from the general population or those living in residential centers. It’s important to note that individuals with certain serious health issues or intellectual disabilities may not be able to participate. If you join the study, you can expect to complete some assessments that help the researchers understand your mental health over time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • French-speaking and French-understanding
  • Subjects who accepted to participated to the study (signature of informed consent/assent document from subjects and parents or legal holder of parental authority)
  • Specific criteria for patients: inpatients and out-patients
  • Specific criteria for control group: youth from general population or placed in residential centres
  • Exclusion Criteria:
  • Impossibility to answer to the assessment tools
  • Medium intellectual disability (homogenous IQ \< 75)
  • Presence of a grave somatic disease (cancer, cardiac failure, renal failure, central nervous system disorder), that is progressive or that affects the vital prognosis in the short term
  • Active participation to another study

About Queen Fabiola Children's University Hospital

Queen Fabiola Children's University Hospital is a premier pediatric institution dedicated to advancing child health through innovative clinical research and compassionate care. As a leading sponsor of clinical trials, the hospital focuses on developing and evaluating new treatments and therapies for various pediatric conditions. With a multidisciplinary team of experienced clinicians and researchers, the institution fosters a collaborative environment that emphasizes patient safety, ethical standards, and the integration of cutting-edge scientific advancements. Through its commitment to enhancing pediatric healthcare, Queen Fabiola Children's University Hospital aims to improve outcomes for children and adolescents on a global scale.

Locations

Brussels, Belgium

Brussels, Belgium

Brussels, Belgium

Brussels, Belgium

Patients applied

0 patients applied

Trial Officials

Véronique Delvenne, MD, PhD

Principal Investigator

Queen Fabiola Children's University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials